Publication: IV thrombolysis and renal function
| dc.contributor.author | Gensicke, Henrik (36554060500) | |
| dc.contributor.author | Zinkstok, Sanne M. (35294364600) | |
| dc.contributor.author | Roos, Yvo B. (7005626073) | |
| dc.contributor.author | Seiffge, David J. (36633290700) | |
| dc.contributor.author | Ringleb, Peter (7003924176) | |
| dc.contributor.author | Artto, Ville (55938125500) | |
| dc.contributor.author | Putaala, Jukka (26531906100) | |
| dc.contributor.author | Haapaniemi, Elena (6602783096) | |
| dc.contributor.author | Leys, Didier (26324692700) | |
| dc.contributor.author | Bordet, Régis (7006636115) | |
| dc.contributor.author | Michel, Patrik (7202280440) | |
| dc.contributor.author | Odier, Céline (26039465700) | |
| dc.contributor.author | Berrouschot, Jörg (6701763644) | |
| dc.contributor.author | Arnold, Marcel (35588830700) | |
| dc.contributor.author | Heldner, Mirjam R. (21934241600) | |
| dc.contributor.author | Zini, Andrea (57879430100) | |
| dc.contributor.author | Bigliardi, Guido (57202572448) | |
| dc.contributor.author | Padjen, Visnja (55605274200) | |
| dc.contributor.author | Peters, Nils (57219322529) | |
| dc.contributor.author | Pezzini, Alessandro (7003431197) | |
| dc.date.accessioned | 2025-06-12T20:48:16Z | |
| dc.date.available | 2025-06-12T20:48:16Z | |
| dc.date.issued | 2013 | |
| dc.description.abstract | Objective: To investigate the association of renal impairment on functional outcome and complications in stroke patients treated with IV thrombolysis (IVT). Methods: In this observational study, we compared the estimated glomerular filtration rate (GFR) with poor 3-month outcome (modified Rankin Scale scores 3-6), death, and symptomatic intracranial hemorrhage (sICH) based on the criteria of the European Cooperative Acute Stroke Study II trial. Unadjusted and adjusted odds ratios (ORs) with 95% confidence intervals (CIs) were calculated. Patients without IVT treatment served as a comparison group. Results: Among 4,780 IVT-treated patients, 1,217 (25.5%) had a low GFR (,60mL/min/1.73m2). A GFR decrease by 10 mL/min/1.73 m2 increased the risk of poor outcome (OR [95% CI]): (ORunadjusted 1.20 [1.17-1.24]; OR adjusted 1.05 [1.01-1.09]), death (ORunadjusted 1.33 [1.28-1.38]; ORadjusted 1.18 [1.11-1.249]), and sICH (OR unadjusted 1.15 [1.01-1.22]; ORadjusted 1.11 [1.04-1.20]). Low GFR was independently associated with poor 3-month outcome (OR adjusted 1.32 [1.10-1.58]), death (ORadjusted 1.73 [1.39-2.14]), and sICH (ORadjusted 1.64 [1.21-2.23]) compared with normal GFR (60-120 mL/min/1.73 m2). Low GFR (ORadjusted 1.64 [1.21-2.23]) and stroke severity (ORadjusted 1.05 [1.03-1.07]) independently determined sICH. Compared with patients who did not receive IVT, treatment with IVT in patients with low GFR was associated with poor outcome (ORadjusted 1.79 [1.41-2.25]), and with favorable outcome in those with normal GFR (ORadjusted 0.77 [0.63-0.94]). Conclusion: Renal function significantly modified outcome and complication rates in IVT-treated stroke patients. Lower GFR might be a better risk indicator for sICH than age. A decrease of GFR by 10 mL/min/1.73 m2 seems to have a similar impact on the risk of death or sICH as a 1-pointhigher NIH Stroke Scale score measuring stroke severity. © 2013 American Academy of Neurology. | |
| dc.identifier.uri | https://doi.org/10.1212/01.wnl.0000435550.83200.9e | |
| dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84888262780&doi=10.1212%2f01.wnl.0000435550.83200.9e&partnerID=40&md5=1f84de40b134e8ac99d829715c37eaea | |
| dc.identifier.uri | https://remedy.med.bg.ac.rs/handle/123456789/8930 | |
| dc.title | IV thrombolysis and renal function | |
| dspace.entity.type | Publication | |
